Indication
Invasive pulmonary aspergillosis
Invasive pulmonary aspergillosis is a severe, life-threatening opportunistic fungal infection of the lower respiratory tract caused by the inhalation of airborne spores from *Aspergillus* species, most commonly *Aspergillus fumigatus*. Read more about Invasive pulmonary aspergillosis
69 drugs 49 manufacturers
Drugs that treat it
Common Invasive pulmonary aspergillosis therapies.
VORICONAZOLE
POSACONAZOLE
POSACONAZOLE
VORICONAZOLE
POSACONAZOLE
POSACONAZOLE
POSACONAZOLE
POSACONAZOLE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonInvasive pulmonary aspergillosis is a severe, life-threatening opportunistic fungal infection of the lower respiratory tract caused by the inhalation of airborne spores from *Aspergillus* species, most commonly *Aspergillus fumigatus*.
It primarily develops in severely immunocompromised individuals—such as patients with prolonged neutropenia, hematologic malignancies, or hematopoietic stem cell and solid organ transplants—as well as critically ill patients with severe viral pneumonia.
Pathophysiologically, the organism invades the bronchial mucosa and surrounding pulmonary parenchyma, exhibiting a characteristic hallmark of angioinvasion that leads to thrombosis, tissue necrosis, pulmonary infarction, and potential hematogenous dissemination.
Patients typically present with fever, cough, dyspnea, pleuritic chest pain, and hemoptysis, often accompanied by characteristic macronodules with surrounding ground-glass attenuation on chest imaging.
- cdc.gov
Invasive pulmonary aspergillosis is a severe, life-threatening opportunistic fungal infection of the lower respiratory tract caused by the inhalation of airborne spores from *Aspergillus* species, most commonly *Aspergillus fumigatus* It primarily develops in severely immunocompromised individuals—such as patients with prolonged neutropenia, hematologic malignancies, or hematopoietic stem cell and solid organ transplants—as well as critically ill patients with severe viral pneumonia Pathophysiol...
- nih.gov
Invasive pulmonary aspergillosis is a severe, life-threatening opportunistic fungal infection of the lower respiratory tract caused by the inhalation of airborne spores from *Aspergillus* species, most commonly *Aspergillus fumigatus*
- nih.gov
It primarily develops in severely immunocompromised individuals—such as patients with prolonged neutropenia, hematologic malignancies, or hematopoietic stem cell and solid organ transplants—as well as critically ill patients with severe viral pneumonia
- cdc.gov
Pathophysiologically, the organism invades the bronchial mucosa and surrounding pulmonary parenchyma, exhibiting a characteristic hallmark of angioinvasion that leads to thrombosis, tissue necrosis, pulmonary infarction, and potential hematogenous dissemination Patients typically present with fever, cough, dyspnea, pleuritic chest pain, and hemoptysis, often accompanied by characteristic macronodules with surrounding ground-glass attenuation on chest imaging
- nih.gov
Pathophysiologically, the organism invades the bronchial mucosa and surrounding pulmonary parenchyma, exhibiting a characteristic hallmark of angioinvasion that leads to thrombosis, tissue necrosis, pulmonary infarction, and potential hematogenous dissemination
- nih.gov
Pathophysiologically, the organism invades the bronchial mucosa and surrounding pulmonary parenchyma, exhibiting a characteristic hallmark of angioinvasion that leads to thrombosis, tissue necrosis, pulmonary infarction, and potential hematogenous dissemination
- nih.gov
Patients typically present with fever, cough, dyspnea, pleuritic chest pain, and hemoptysis, often accompanied by characteristic macronodules with surrounding ground-glass attenuation on chest imaging
Personalize your experience
Follow Invasive pulmonary aspergillosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.